These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 25026957)

  • 1. No relation between CMV infection and mortality in the oldest old: results from the Belfrail study.
    Matheï C; Adriaensen W; Vaes B; Van Pottelbergh G; Wallemacq P; Degryse J
    Age Ageing; 2015 Jan; 44(1):130-5. PubMed ID: 25026957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of Cytomegalovirus Infection With All-Cause and Cardiovascular Mortality in Multiple Observational Cohort Studies of Older Adults.
    Chen S; Pawelec G; Trompet S; Goldeck D; Mortensen LH; Slagboom PE; Christensen K; Gussekloo J; Kearney P; Buckley BM; Ford I; Jukema JW; Westendorp RGJ; Maier AB
    J Infect Dis; 2021 Feb; 223(2):238-246. PubMed ID: 32909605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4:8 Ratio Above 5 Is Associated With All-Cause Mortality in CMV-Seronegative Very Old Women: Results From the BELFRAIL Study.
    Adriaensen W; Pawelec G; Vaes B; Hamprecht K; Derhovanessian E; van Pottelbergh G; Degryse JM; Matheï C
    J Gerontol A Biol Sci Med Sci; 2017 Sep; 72(9):1155-1162. PubMed ID: 27927759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between cytomegalovirus infection and functional impairment and frailty in the BELFRAIL Cohort.
    Matheï C; Vaes B; Wallemacq P; Degryse J
    J Am Geriatr Soc; 2011 Dec; 59(12):2201-8. PubMed ID: 22092044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytomegalovirus infection: its incidence and management in cytomegalovirus-seropositive living related liver transplant recipients: a single-center experience.
    Wadhawan M; Gupta S; Goyal N; Vasudevan KR; Makki K; Dawar R; Sardana R; Lal N; Kumar A
    Liver Transpl; 2012 Dec; 18(12):1448-55. PubMed ID: 22903934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus seropositivity and C-reactive protein have independent and combined predictive value for mortality in patients with angiographically demonstrated coronary artery disease.
    Muhlestein JB; Horne BD; Carlquist JF; Madsen TE; Bair TL; Pearson RR; Anderson JL
    Circulation; 2000 Oct; 102(16):1917-23. PubMed ID: 11034939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus infection and the risk of mortality and frailty in older women: a prospective observational cohort study.
    Wang GC; Kao WH; Murakami P; Xue QL; Chiou RB; Detrick B; McDyer JF; Semba RD; Casolaro V; Walston JD; Fried LP
    Am J Epidemiol; 2010 May; 171(10):1144-52. PubMed ID: 20400465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective study of cytomegalovirus seropositivity and risk of mortality from diabetes.
    Mendy A; Gasana J; Vieira ER; Diallo H
    Acta Diabetol; 2014 Oct; 51(5):723-9. PubMed ID: 24633860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased levels of tumor necrosis factor alpha are associated with an increased risk of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation.
    Reddy V; Meier-Kriesche HU; Greene S; Schold JD; Wingard JR
    Biol Blood Marrow Transplant; 2005 Sep; 11(9):698-705. PubMed ID: 16125640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus is associated with depression and anxiety in older adults.
    Phillips AC; Carroll D; Khan N; Moss P
    Brain Behav Immun; 2008 Jan; 22(1):52-5. PubMed ID: 17703915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4:8 ratio >5 is associated with a dominant naive T-cell phenotype and impaired physical functioning in CMV-seropositive very elderly people: results from the BELFRAIL study.
    Adriaensen W; Derhovanessian E; Vaes B; Van Pottelbergh G; Degryse JM; Pawelec G; Hamprecht K; Theeten H; Matheï C
    J Gerontol A Biol Sci Med Sci; 2015 Feb; 70(2):143-54. PubMed ID: 24568932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus antibody levels and mortality among hospitalised elderly patients.
    González-Quijada S; Del Álamo-Martínez de Lagos M; Álvarez-Llabrés M; Pérez-González L
    Ann Med; 2020 Dec; 52(8):497-505. PubMed ID: 32803995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease.
    Strandberg TE; Pitkala KH; Tilvis RS
    JAMA; 2009 Jan; 301(4):380-2. PubMed ID: 19176439
    [No Abstract]   [Full Text] [Related]  

  • 15. Seropositivity and higher immunoglobulin g antibody levels against cytomegalovirus are associated with mortality in the population-based European prospective investigation of Cancer-Norfolk cohort.
    Gkrania-Klotsas E; Langenberg C; Sharp SJ; Luben R; Khaw KT; Wareham NJ
    Clin Infect Dis; 2013 May; 56(10):1421-7. PubMed ID: 23442763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with the development of cytomegalovirus infection following solid organ transplantation.
    da Cunha-Bang C; Sørensen SS; Iversen M; Sengeløv H; Hillingsø JG; Rasmussen A; Mortensen SA; Fox ZV; Kirkby NS; Christiansen CB; Lundgren JD
    Scand J Infect Dis; 2011 May; 43(5):360-5. PubMed ID: 21306196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donor serostatus has an impact on cytomegalovirus-specific immunity, cytomegaloviral disease incidence, and survival in seropositive hematopoietic cell transplant recipients.
    Ugarte-Torres A; Hoegh-Petersen M; Liu Y; Zhou F; Williamson TS; Quinlan D; Sy S; Roa L; Khan F; Fonseca K; Russell JA; Storek J
    Biol Blood Marrow Transplant; 2011 Apr; 17(4):574-85. PubMed ID: 20688181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].
    Cartón JA; Maradona JA; de Oña M; Asensi V; Melón S; García-Alcalde ML; Rodríguez-Junquera M; Moreno-Torrico A; de Zárraga M
    Med Clin (Barc); 1999 Sep; 113(6):205-9. PubMed ID: 10472608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects.
    Just-Nübling G; Korn S; Ludwig B; Stephan C; Doerr HW; Preiser W
    Infection; 2003 Oct; 31(5):318-23. PubMed ID: 14556056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection is associated with increased mortality in the older population.
    Savva GM; Pachnio A; Kaul B; Morgan K; Huppert FA; Brayne C; Moss PA;
    Aging Cell; 2013 Jun; 12(3):381-7. PubMed ID: 23442093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.